User menu

New adipokines identified as downstream targets for adiponectin: lessons from adiponectin-overexpressing or deficient-mice

Bibliographic reference Ge, Qian ; Rycken, L. ; Noel, Laurence ; Brichard, Sonia. New adipokines identified as downstream targets for adiponectin: lessons from adiponectin-overexpressing or deficient-mice.46th Annual Meeting of the European-Association-for-the- Study-of-Diabetes (EASD) (Stockholm (Sweden), Sep 20-24, 2010). In: Diabetologia : clinical and experimental diabetes and metabolism, Vol. 53, p. S58-S59 (2010)
Permanent URL
  1. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053
  2. Ferri CP, Prince M, Brayne C et al (2005) Global prevalence of dementia: a Delphi consensus study. Lancet 366:2112–2117
  3. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P (2006) Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 5:64–74
  4. Ryan CM, Geckle MO (2000) Circumscribed cognitive dysfunction in middle-aged adults with type 2 diabetes. Diabetes Care 23:1486–1493
  5. Dey J, Misra A, Desai NG, Mahapatra AK, Padma MV (1997) Cognitive function in younger type II diabetes. Diabetes Care 20:32–35
  6. Awad N, Gagnon M, Messier C (2004) The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. J Clin Exp Neuropsychol 26:1044–1080
  7. Stewart R, Liolitsa D (1999) Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet Med 16:93–112
  8. BRANDS AUGUSTINA M.A., VAN DEN BERG ESTHER, MANSCHOT SANNE M., BIESSELS GEERT JAN, KAPPELLE L. JAAP, DE HAAN EDWARD H.F., KESSELS ROY P.C., A detailed profile of cognitive dysfunction and its relation to psychological distress in patients with type 2 diabetes mellitus, 10.1017/s1355617707070312
  9. Gregg EW, Mangione CM, Cauley JA et al (2002) Diabetes and incidence of functional disability in older women. Diabetes Care 25:61–67
  10. Kanaya AM, Barrett-Connor E, Gildengorin G, Yaffe K (2004) Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med 164:1327–1333
  11. Manschot SM, Brands AM, van der Grond J et al (2006) Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 55:1106–1113
  12. Kempen GI, Meier AJ, Bouwens SF, van Deursen J, Verhey FR (2007) The psychometric properties of the Dutch version of the Telephone Interview Cognitive Status (TICS). Tijdschr Gerontol Geriatr 38:38–45
  13. Brandt J, Spencer M, Folstein M (1988) The telephone interview for cognitive status. Neuropsychiatry Neuropsychol Behav Neurol 2:111–117
  14. Welsh KA, Breitner JCS, Magruder-Habib KM (1993) Detection of dementia in the elderly using telephone screening of cognitive status. Neuropsychiatry Neuropsychol Behav Neurol 6:103–110
  15. Crooks VC, Clark L, Petitti DB, Chui H, Chiu V (2005) Validation of multi-stage telephone-based identification of cognitive impairment and dementia. BMC Neurol 5:8
  16. Lezak MD, Howieson DB, Loring DW (2004) Neuropsychological assessment, 4th edn. Oxford University Press, New York
  17. Kessels RP, van Zandvoort MJ, Postma A, Kappelle LJ, de Haan EH (2000) The Corsi Block-Tapping Task: standardization and normative data. Appl Neuropsychol 7:252–258
  18. Beck AT, Steer RA, Brown GK (1996) Manual for Beck Depression Inventory II (BDI-II). Psychology Corporation, San Antonio
  19. Lustman Patrick J., Clouse Ray E., Griffith Linda S., Carney Robert M., Freedland Kenneth E., Screening for Depression in Diabetes Using the Beck Depression Inventory : , 10.1097/00006842-199701000-00004
  20. Klein Ronald, Klein Barbara E.K., Magli Yvonne L., Brothers Rosemary J., Meuer Stacy M., Moss Scot E., Davis Matthew D., An Alternative Method of Grading Diabetic Retinopathy, 10.1016/s0161-6420(86)33606-6
  21. Bril V, Perkins BA (2002) Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy. Diabetes Care 25:2048–2052
  22. Manschot SM, Biessels GJ, de Valk H et al (2007) Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes. Diabetologia 50:2388–2397
  23. van Harten B, Oosterman J, Muslimovic D, van Loon BJ, Scheltens P, Weinstein HC (2007) Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus. Age Ageing 36:164–170
  24. Vanhanen M, Koivisto K, Kuusisto J et al (1998) Cognitive function in an elderly population with persistent impaired glucose tolerance. Diabetes Care 21:398–402
  25. Ruis C, Biessels GJ, Gorter KJ, van den Donk M, Kappelle LJ, Rutten GE (2009) Cognition in the early stage of type 2 diabetes mellitus. Diabetes Care 32:1261–1265
  26. Fischer AL, de Frias CM, Yeung SE, Dixon RA (2009) Short-term longitudinal trends in cognitive performance in older adults with type 2 diabetes. J Clin Exp Neuropsychol 31:809–822
  27. Aberle I, Kliegel M, Zimprich D (2009) Cognitive development in young-old type 2 diabetes patients: a longitudinal analysis from the ‘Interdisciplinary Longitudinal Study of Aging’. Curr Psychol 27:6–15
  28. Kumari M, Marmot M (2005) Diabetes and cognitive function in a middle-aged cohort: findings from the Whitehall II study. Neurology 65:1597–1603
  29. Fontbonne A, Berr C, Ducimetiere P, Alperovitch A (2001) Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care 24:366–370
  30. Cox DJ, Kovatchev BP, Gonder-Frederick LA et al (2005) Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes. Diabetes Care 28:71–77
  31. Jacobson AM, Musen G, Ryan CM et al (2007) Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 356:1842–1852
  32. Peila R, Rodriguez BL, Launer LJ (2002) Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes 51:1256–1262
  33. Luchsinger JA, Reitz C, Honig LS, Tang MX, Shea S, Mayeux R (2005) Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 65:545–551
  34. Sandbaek A, Griffin SJ, Rutten G et al (2008) Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study. Diabetologia 51:1127–1134
  35. Launer L. J., Andersen K., Dewey M. E., Letenneur L., Ott A., Amaducci L. A., Brayne C., Copeland J. R. M., Dartigues J.-F., Kragh-Sorensen P., Lobo A., Martinez-Lage J. M., Stijnen T., Hofman A., Rates and risk factors for dementia and Alzheimer's disease: Results from EURODEM pooled analyses, 10.1212/wnl.52.1.78
  36. Tisserand DJ, Jolles J (2003) On the involvement of prefrontal networks in cognitive ageing. Cortex 39:1107–1128